News IBM Watson to help personalise cancer care in China Watson for Oncology will be deployed across 21 Chinese hospitals to aid in care decisions.
News Nanorobots developed to target cancer inside the body Bacteria-based nanorobots deliver chemo direct to tumour in mice
Views & Analysis Promise for combination approach to cancer As immuno-oncology increasingly involves more than one agent for best efficacy, market positioning must take a pan-tumour approach.
News NICE recommends Amgen’s melanoma treatment after price cut Drug only approved when systemic immunotherapies are not suitable
News Adcetris falls victim to NICE’s Cancer Drugs Fund clear-out More CDF legacy products likely to face same fate
Cancer Lilly’s wait for breast cancer data will help rivals Setback for Lilly as it looks to develop best-in-class product
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
